The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
Related Posts
Factories Were Pushed Out of Cities. Their Return Could Revive Downtowns.
Changes in zoning rules have allowed small manufacturers to return to the districts and neighborhoods they began leaving a century…
Despite Dire Warnings, the Economy Is Holding Up. Can That Last?
Economists say it will take time for the effects of trade policies to show up in economic data — but…
Five Key Takeaways From the Supreme Court Tariff Argument
The Supreme Court justices grappled with the legality of President Trump’s tariffs in an oral argument that stretched for almost…